Healthcare provider profile · identity verified

Benjamin Allen Voss, MD

Internal Medicine · SAINT LOUIS, MO · NPI 1053517656

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1136	311
Losartan Potassium	Losartan Potassium	612	175
Amlodipine Besylate	Amlodipine Besylate	470	142
Metoprolol Succinate	Metoprolol Succinate	411	116
Levothyroxine Sodium	Levothyroxine Sodium	389	107
Lisinopril	Lisinopril	389	107
Eliquis	Apixaban	307	71
Omeprazole	Omeprazole	275	80
Furosemide	Furosemide	265	85
Rosuvastatin Calcium	Rosuvastatin Calcium	259	86
Trazodone Hcl	Trazodone Hcl	231	69
Gabapentin	Gabapentin	228	74
Tamsulosin Hcl	Tamsulosin Hcl	208	56
Metformin Hcl Er	Metformin Hcl	205	64
Duloxetine Hcl	Duloxetine Hcl	186	52
Sertraline Hcl	Sertraline Hcl	185	47
Hydrochlorothiazide	Hydrochlorothiazide	182	53
Pravastatin Sodium	Pravastatin Sodium	155	46
Pantoprazole Sodium	Pantoprazole Sodium	136	42
Simvastatin	Simvastatin	134	40
Trulicity	Dulaglutide	123	30
Lorazepam	Lorazepam	122	31
Escitalopram Oxalate	Escitalopram Oxalate	121	36
Ozempic	Semaglutide	120	25
Metformin Hcl	Metformin Hcl	118	35
Allopurinol	Allopurinol	116	34
Potassium Chloride	Potassium Chloride	112	31
Spironolactone	Spironolactone	107	31
Jardiance	Empagliflozin	101	27
Tramadol Hcl	Tramadol Hcl	96	38
Alprazolam	Alprazolam	95	22
Celecoxib	Celecoxib	92	30
Finasteride	Finasteride	90	31
Metoprolol Tartrate	Metoprolol Tartrate	85	27
Albuterol Sulfate Hfa	Albuterol Sulfate	76	30
Carvedilol	Carvedilol	70	20
Bupropion Xl	Bupropion Hcl	69	25
Montelukast Sodium	Montelukast Sodium	67	21
Fluticasone Propionate	Fluticasone Propionate	66	25
Venlafaxine Hcl Er	Venlafaxine Hcl	64	17
Arexvy	Rsvpref3 Antigen/As01e/Pf	60	60
Clopidogrel	Clopidogrel Bisulfate	60	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	25
Raloxifene Hcl	Raloxifene Hcl	54	16
Synthroid	Levothyroxine Sodium	53	16
Zolpidem Tartrate	Zolpidem Tartrate	53	15
Warfarin Sodium	Warfarin Sodium	49	suppressed
Atenolol	Atenolol	47	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	12
Doxazosin Mesylate	Doxazosin Mesylate	44	11
Propranolol Hcl Er	Propranolol Hcl	44	13
Ezetimibe	Ezetimibe	43	14
Donepezil Hcl	Donepezil Hcl	42	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	14
Terazosin Hcl	Terazosin Hcl	41	11
Xarelto	Rivaroxaban	41	suppressed
Farxiga	Dapagliflozin Propanediol	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	11
Valacyclovir	Valacyclovir Hcl	40	14
Pregabalin	Pregabalin	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	38	suppressed
Famotidine	Famotidine	37	11
Testosterone Cypionate	Testosterone Cypionate	37	suppressed
Torsemide	Torsemide	37	14
Alendronate Sodium	Alendronate Sodium	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Mounjaro	Tirzepatide	34	suppressed
Ondansetron Odt	Ondansetron	34	16
Ramipril	Ramipril	34	suppressed
Loperamide	Loperamide Hcl	33	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	29	suppressed
Baclofen	Baclofen	28	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Mirtazapine	Mirtazapine	27	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	22
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	23
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Klor-Con M20	Potassium Chloride	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	12
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Prednisone	Prednisone	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Azithromycin	Azithromycin	13	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Colchicine	Colchicine	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Valsartan	Valsartan	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error